By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Laboratory Corporation of America announced today that it has extended its tender offer for all of the outstanding shares of Orchid Cellmark until 6:00 p.m., New York City time, on June 15, 2011.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.
Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.
The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.
Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.